Global Targeted Therapy Drugs for Cancer Market Growth 2026-2032
The global Targeted Therapy Drugs for Cancer market size is predicted to grow from US$ 118360 million in 2025 to US$ 191441 million in 2032; it is expected to grow at a CAGR of 7.6% from 2026 to 2032.
In 2025, global Targeted Therapy Drugs for Cancer reached approximately 58.76 M Units, with an average global market price of around 2059 USD per Unit.
Targeted therapy drugs for cancer are anticancer medicines designed to specifically interfere with molecular targets—such as mutated genes, abnormal proteins, or dysregulated signaling pathways—that drive the growth, survival, or spread of cancer cells. These targets are typically involved in processes like cell proliferation, angiogenesis, DNA repair, or immune evasion, and are more active or uniquely altered in cancer cells compared with normal cells.
Unlike traditional chemotherapy, which broadly affects rapidly dividing cells, targeted cancer therapies act in a more precise and mechanism-driven manner, aiming to block cancer-specific biological processes while minimizing damage to healthy tissues. They include small-molecule drugs (often taken orally and acting inside cells) and biologic agents such as monoclonal antibodies (usually acting on cell-surface targets or extracellular ligands). Targeted therapies are commonly selected based on biomarker or genetic testing, making them a central component of precision oncology.
The upstream raw materials for Targeted Therapy Drugs for Cancer mainly include active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and excipients. Typical suppliers include Pfizer, Roche, Merck, and AstraZeneca. Downstream applications are primarily in oncology and rare disease treatments.
The single-line production capacity of Targeted Therapy Drugs for Cancer varies significantly depending on the drug molecule type, process complexity, equipment scale, and production mode. Industry gross margins typically range from 60% to 80%.
United States market for Targeted Therapy Drugs for Cancer is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Targeted Therapy Drugs for Cancer is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Targeted Therapy Drugs for Cancer is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Targeted Therapy Drugs for Cancer players cover Roche, Novartis, Merck, Pfizer, AstraZeneca, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Targeted Therapy Drugs for Cancer Industry Forecast” looks at past sales and reviews total world Targeted Therapy Drugs for Cancer sales in 2025, providing a comprehensive analysis by region and market sector of projected Targeted Therapy Drugs for Cancer sales for 2026 through 2032. With Targeted Therapy Drugs for Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Therapy Drugs for Cancer industry.
This Insight Report provides a comprehensive analysis of the global Targeted Therapy Drugs for Cancer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Targeted Therapy Drugs for Cancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Therapy Drugs for Cancer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Therapy Drugs for Cancer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Therapy Drugs for Cancer.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Therapy Drugs for Cancer market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
In 2025, global Targeted Therapy Drugs for Cancer reached approximately 58.76 M Units, with an average global market price of around 2059 USD per Unit.
Targeted therapy drugs for cancer are anticancer medicines designed to specifically interfere with molecular targets—such as mutated genes, abnormal proteins, or dysregulated signaling pathways—that drive the growth, survival, or spread of cancer cells. These targets are typically involved in processes like cell proliferation, angiogenesis, DNA repair, or immune evasion, and are more active or uniquely altered in cancer cells compared with normal cells.
Unlike traditional chemotherapy, which broadly affects rapidly dividing cells, targeted cancer therapies act in a more precise and mechanism-driven manner, aiming to block cancer-specific biological processes while minimizing damage to healthy tissues. They include small-molecule drugs (often taken orally and acting inside cells) and biologic agents such as monoclonal antibodies (usually acting on cell-surface targets or extracellular ligands). Targeted therapies are commonly selected based on biomarker or genetic testing, making them a central component of precision oncology.
The upstream raw materials for Targeted Therapy Drugs for Cancer mainly include active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and excipients. Typical suppliers include Pfizer, Roche, Merck, and AstraZeneca. Downstream applications are primarily in oncology and rare disease treatments.
The single-line production capacity of Targeted Therapy Drugs for Cancer varies significantly depending on the drug molecule type, process complexity, equipment scale, and production mode. Industry gross margins typically range from 60% to 80%.
United States market for Targeted Therapy Drugs for Cancer is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Targeted Therapy Drugs for Cancer is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Targeted Therapy Drugs for Cancer is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Targeted Therapy Drugs for Cancer players cover Roche, Novartis, Merck, Pfizer, AstraZeneca, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Targeted Therapy Drugs for Cancer Industry Forecast” looks at past sales and reviews total world Targeted Therapy Drugs for Cancer sales in 2025, providing a comprehensive analysis by region and market sector of projected Targeted Therapy Drugs for Cancer sales for 2026 through 2032. With Targeted Therapy Drugs for Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Therapy Drugs for Cancer industry.
This Insight Report provides a comprehensive analysis of the global Targeted Therapy Drugs for Cancer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Targeted Therapy Drugs for Cancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Therapy Drugs for Cancer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Therapy Drugs for Cancer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Therapy Drugs for Cancer.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Therapy Drugs for Cancer market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Kinase Inhibitors
- ADCs
- Others
- Oral Drugs
- Injectable Drugs
- Others
- Small Molecule Drugs
- Antibody Drugs
- Others
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Stomach Cancer
- Liver Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Novartis
- Merck
- Pfizer
- AstraZeneca
- Johnson & Johnson
- Bristol Myers Squibb
- Bayer
- GSK
- Daiichi Sankyo
- Amgen
- Eli Lilly and Company
- AbbVie
- Sanofi
- Takeda
- Boehringer Ingelheim
- Beigene, Ltd.
- Jiangsu Hengrui Medicine
- INNOVENT BIOLOGICS(SUZHOU)
- Betta Pharmaceuticals
- Remegen Co.,Ltd.
- Shanghai Allist Pharmaceuticals
- Innocare
- Huiyu Pharmaceuticals
- What is the 10-year outlook for the global Targeted Therapy Drugs for Cancer market?
- What factors are driving Targeted Therapy Drugs for Cancer market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Targeted Therapy Drugs for Cancer market opportunities vary by end market size?
- How does Targeted Therapy Drugs for Cancer break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Therapy Drugs for Cancer Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Targeted Therapy Drugs for Cancer by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Targeted Therapy Drugs for Cancer by Country/Region, 2021, 2025 & 2032
2.2 Targeted Therapy Drugs for Cancer Segment by Type
2.2.1 Kinase Inhibitors
2.2.2 ADCs
2.2.3 Others
2.2.4 Targeted Therapy Drugs for Cancer Sales by Type
2.2.4.1 Global Targeted Therapy Drugs for Cancer Sales Market Share by Type (2021-2026)
2.2.4.2 Global Targeted Therapy Drugs for Cancer Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Targeted Therapy Drugs for Cancer Sale Price by Type (2021-2026)
2.3 Targeted Therapy Drugs for Cancer Segment by Administration Route
2.3.1 Oral Drugs
2.3.2 Injectable Drugs
2.3.3 Others
2.3.4 Targeted Therapy Drugs for Cancer Sales by Administration Route
2.3.4.1 Global Targeted Therapy Drugs for Cancer Sales Market Share by Administration Route (2021-2026)
2.3.4.2 Global Targeted Therapy Drugs for Cancer Revenue and Market Share by Administration Route (2021-2026)
2.3.4.3 Global Targeted Therapy Drugs for Cancer Sale Price by Administration Route (2021-2026)
2.4 Targeted Therapy Drugs for Cancer Segment by Molecular Properties
2.4.1 Small Molecule Drugs
2.4.2 Antibody Drugs
2.4.3 Others
2.4.4 Targeted Therapy Drugs for Cancer Sales by Molecular Properties
2.4.4.1 Global Targeted Therapy Drugs for Cancer Sales Market Share by Molecular Properties (2021-2026)
2.4.4.2 Global Targeted Therapy Drugs for Cancer Revenue and Market Share by Molecular Properties (2021-2026)
2.4.4.3 Global Targeted Therapy Drugs for Cancer Sale Price by Molecular Properties (2021-2026)
2.5 Targeted Therapy Drugs for Cancer Segment by Application
2.5.1 Lung Cancer
2.5.2 Breast Cancer
2.5.3 Colorectal Cancer
2.5.4 Stomach Cancer
2.5.5 Liver Cancer
2.5.6 Others
2.5.7 Targeted Therapy Drugs for Cancer Sales by Application
2.5.7.1 Global Targeted Therapy Drugs for Cancer Sale Market Share by Application (2021-2026)
2.5.7.2 Global Targeted Therapy Drugs for Cancer Revenue and Market Share by Application (2021-2026)
2.5.7.3 Global Targeted Therapy Drugs for Cancer Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Targeted Therapy Drugs for Cancer Breakdown Data by Company
3.1.1 Global Targeted Therapy Drugs for Cancer Annual Sales by Company (2021-2026)
3.1.2 Global Targeted Therapy Drugs for Cancer Sales Market Share by Company (2021-2026)
3.2 Global Targeted Therapy Drugs for Cancer Annual Revenue by Company (2021-2026)
3.2.1 Global Targeted Therapy Drugs for Cancer Revenue by Company (2021-2026)
3.2.2 Global Targeted Therapy Drugs for Cancer Revenue Market Share by Company (2021-2026)
3.3 Global Targeted Therapy Drugs for Cancer Sale Price by Company
3.4 Key Manufacturers Targeted Therapy Drugs for Cancer Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Targeted Therapy Drugs for Cancer Product Location Distribution
3.4.2 Players Targeted Therapy Drugs for Cancer Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TARGETED THERAPY DRUGS FOR CANCER BY GEOGRAPHIC REGION
4.1 World Historic Targeted Therapy Drugs for Cancer Market Size by Geographic Region (2021-2026)
4.1.1 Global Targeted Therapy Drugs for Cancer Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Targeted Therapy Drugs for Cancer Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Targeted Therapy Drugs for Cancer Market Size by Country/Region (2021-2026)
4.2.1 Global Targeted Therapy Drugs for Cancer Annual Sales by Country/Region (2021-2026)
4.2.2 Global Targeted Therapy Drugs for Cancer Annual Revenue by Country/Region (2021-2026)
4.3 Americas Targeted Therapy Drugs for Cancer Sales Growth
4.4 APAC Targeted Therapy Drugs for Cancer Sales Growth
4.5 Europe Targeted Therapy Drugs for Cancer Sales Growth
4.6 Middle East & Africa Targeted Therapy Drugs for Cancer Sales Growth
5 AMERICAS
5.1 Americas Targeted Therapy Drugs for Cancer Sales by Country
5.1.1 Americas Targeted Therapy Drugs for Cancer Sales by Country (2021-2026)
5.1.2 Americas Targeted Therapy Drugs for Cancer Revenue by Country (2021-2026)
5.2 Americas Targeted Therapy Drugs for Cancer Sales by Type (2021-2026)
5.3 Americas Targeted Therapy Drugs for Cancer Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Therapy Drugs for Cancer Sales by Region
6.1.1 APAC Targeted Therapy Drugs for Cancer Sales by Region (2021-2026)
6.1.2 APAC Targeted Therapy Drugs for Cancer Revenue by Region (2021-2026)
6.2 APAC Targeted Therapy Drugs for Cancer Sales by Type (2021-2026)
6.3 APAC Targeted Therapy Drugs for Cancer Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Targeted Therapy Drugs for Cancer by Country
7.1.1 Europe Targeted Therapy Drugs for Cancer Sales by Country (2021-2026)
7.1.2 Europe Targeted Therapy Drugs for Cancer Revenue by Country (2021-2026)
7.2 Europe Targeted Therapy Drugs for Cancer Sales by Type (2021-2026)
7.3 Europe Targeted Therapy Drugs for Cancer Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Therapy Drugs for Cancer by Country
8.1.1 Middle East & Africa Targeted Therapy Drugs for Cancer Sales by Country (2021-2026)
8.1.2 Middle East & Africa Targeted Therapy Drugs for Cancer Revenue by Country (2021-2026)
8.2 Middle East & Africa Targeted Therapy Drugs for Cancer Sales by Type (2021-2026)
8.3 Middle East & Africa Targeted Therapy Drugs for Cancer Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Targeted Therapy Drugs for Cancer
10.3 Manufacturing Process Analysis of Targeted Therapy Drugs for Cancer
10.4 Industry Chain Structure of Targeted Therapy Drugs for Cancer
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Targeted Therapy Drugs for Cancer Distributors
11.3 Targeted Therapy Drugs for Cancer Customer
12 WORLD FORECAST REVIEW FOR TARGETED THERAPY DRUGS FOR CANCER BY GEOGRAPHIC REGION
12.1 Global Targeted Therapy Drugs for Cancer Market Size Forecast by Region
12.1.1 Global Targeted Therapy Drugs for Cancer Forecast by Region (2027-2032)
12.1.2 Global Targeted Therapy Drugs for Cancer Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Targeted Therapy Drugs for Cancer Forecast by Type (2027-2032)
12.7 Global Targeted Therapy Drugs for Cancer Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.1.3 Roche Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.2.3 Novartis Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.3.3 Merck Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.4.3 Pfizer Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.5.3 AstraZeneca Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.6.3 Johnson & Johnson Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 Bristol Myers Squibb
13.7.1 Bristol Myers Squibb Company Information
13.7.2 Bristol Myers Squibb Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.7.3 Bristol Myers Squibb Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Bristol Myers Squibb Main Business Overview
13.7.5 Bristol Myers Squibb Latest Developments
13.8 Bayer
13.8.1 Bayer Company Information
13.8.2 Bayer Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.8.3 Bayer Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bayer Main Business Overview
13.8.5 Bayer Latest Developments
13.9 GSK
13.9.1 GSK Company Information
13.9.2 GSK Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.9.3 GSK Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 GSK Main Business Overview
13.9.5 GSK Latest Developments
13.10 Daiichi Sankyo
13.10.1 Daiichi Sankyo Company Information
13.10.2 Daiichi Sankyo Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.10.3 Daiichi Sankyo Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Daiichi Sankyo Main Business Overview
13.10.5 Daiichi Sankyo Latest Developments
13.11 Amgen
13.11.1 Amgen Company Information
13.11.2 Amgen Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.11.3 Amgen Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Amgen Main Business Overview
13.11.5 Amgen Latest Developments
13.12 Eli Lilly and Company
13.12.1 Eli Lilly and Company Company Information
13.12.2 Eli Lilly and Company Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.12.3 Eli Lilly and Company Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Eli Lilly and Company Main Business Overview
13.12.5 Eli Lilly and Company Latest Developments
13.13 AbbVie
13.13.1 AbbVie Company Information
13.13.2 AbbVie Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.13.3 AbbVie Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 AbbVie Main Business Overview
13.13.5 AbbVie Latest Developments
13.14 Sanofi
13.14.1 Sanofi Company Information
13.14.2 Sanofi Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.14.3 Sanofi Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Sanofi Main Business Overview
13.14.5 Sanofi Latest Developments
13.15 Takeda
13.15.1 Takeda Company Information
13.15.2 Takeda Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.15.3 Takeda Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Takeda Main Business Overview
13.15.5 Takeda Latest Developments
13.16 Boehringer Ingelheim
13.16.1 Boehringer Ingelheim Company Information
13.16.2 Boehringer Ingelheim Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.16.3 Boehringer Ingelheim Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Boehringer Ingelheim Main Business Overview
13.16.5 Boehringer Ingelheim Latest Developments
13.17 Beigene, Ltd.
13.17.1 Beigene, Ltd. Company Information
13.17.2 Beigene, Ltd. Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.17.3 Beigene, Ltd. Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Beigene, Ltd. Main Business Overview
13.17.5 Beigene, Ltd. Latest Developments
13.18 Jiangsu Hengrui Medicine
13.18.1 Jiangsu Hengrui Medicine Company Information
13.18.2 Jiangsu Hengrui Medicine Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.18.3 Jiangsu Hengrui Medicine Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Jiangsu Hengrui Medicine Main Business Overview
13.18.5 Jiangsu Hengrui Medicine Latest Developments
13.19 INNOVENT BIOLOGICS(SUZHOU)
13.19.1 INNOVENT BIOLOGICS(SUZHOU) Company Information
13.19.2 INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.19.3 INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 INNOVENT BIOLOGICS(SUZHOU) Main Business Overview
13.19.5 INNOVENT BIOLOGICS(SUZHOU) Latest Developments
13.20 Betta Pharmaceuticals
13.20.1 Betta Pharmaceuticals Company Information
13.20.2 Betta Pharmaceuticals Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.20.3 Betta Pharmaceuticals Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Betta Pharmaceuticals Main Business Overview
13.20.5 Betta Pharmaceuticals Latest Developments
13.21 Remegen Co.,Ltd.
13.21.1 Remegen Co.,Ltd. Company Information
13.21.2 Remegen Co.,Ltd. Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.21.3 Remegen Co.,Ltd. Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Remegen Co.,Ltd. Main Business Overview
13.21.5 Remegen Co.,Ltd. Latest Developments
13.22 Shanghai Allist Pharmaceuticals
13.22.1 Shanghai Allist Pharmaceuticals Company Information
13.22.2 Shanghai Allist Pharmaceuticals Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.22.3 Shanghai Allist Pharmaceuticals Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Shanghai Allist Pharmaceuticals Main Business Overview
13.22.5 Shanghai Allist Pharmaceuticals Latest Developments
13.23 Innocare
13.23.1 Innocare Company Information
13.23.2 Innocare Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.23.3 Innocare Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Innocare Main Business Overview
13.23.5 Innocare Latest Developments
13.24 Huiyu Pharmaceuticals
13.24.1 Huiyu Pharmaceuticals Company Information
13.24.2 Huiyu Pharmaceuticals Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.24.3 Huiyu Pharmaceuticals Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Huiyu Pharmaceuticals Main Business Overview
13.24.5 Huiyu Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Therapy Drugs for Cancer Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Targeted Therapy Drugs for Cancer by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Targeted Therapy Drugs for Cancer by Country/Region, 2021, 2025 & 2032
2.2 Targeted Therapy Drugs for Cancer Segment by Type
2.2.1 Kinase Inhibitors
2.2.2 ADCs
2.2.3 Others
2.2.4 Targeted Therapy Drugs for Cancer Sales by Type
2.2.4.1 Global Targeted Therapy Drugs for Cancer Sales Market Share by Type (2021-2026)
2.2.4.2 Global Targeted Therapy Drugs for Cancer Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Targeted Therapy Drugs for Cancer Sale Price by Type (2021-2026)
2.3 Targeted Therapy Drugs for Cancer Segment by Administration Route
2.3.1 Oral Drugs
2.3.2 Injectable Drugs
2.3.3 Others
2.3.4 Targeted Therapy Drugs for Cancer Sales by Administration Route
2.3.4.1 Global Targeted Therapy Drugs for Cancer Sales Market Share by Administration Route (2021-2026)
2.3.4.2 Global Targeted Therapy Drugs for Cancer Revenue and Market Share by Administration Route (2021-2026)
2.3.4.3 Global Targeted Therapy Drugs for Cancer Sale Price by Administration Route (2021-2026)
2.4 Targeted Therapy Drugs for Cancer Segment by Molecular Properties
2.4.1 Small Molecule Drugs
2.4.2 Antibody Drugs
2.4.3 Others
2.4.4 Targeted Therapy Drugs for Cancer Sales by Molecular Properties
2.4.4.1 Global Targeted Therapy Drugs for Cancer Sales Market Share by Molecular Properties (2021-2026)
2.4.4.2 Global Targeted Therapy Drugs for Cancer Revenue and Market Share by Molecular Properties (2021-2026)
2.4.4.3 Global Targeted Therapy Drugs for Cancer Sale Price by Molecular Properties (2021-2026)
2.5 Targeted Therapy Drugs for Cancer Segment by Application
2.5.1 Lung Cancer
2.5.2 Breast Cancer
2.5.3 Colorectal Cancer
2.5.4 Stomach Cancer
2.5.5 Liver Cancer
2.5.6 Others
2.5.7 Targeted Therapy Drugs for Cancer Sales by Application
2.5.7.1 Global Targeted Therapy Drugs for Cancer Sale Market Share by Application (2021-2026)
2.5.7.2 Global Targeted Therapy Drugs for Cancer Revenue and Market Share by Application (2021-2026)
2.5.7.3 Global Targeted Therapy Drugs for Cancer Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Targeted Therapy Drugs for Cancer Breakdown Data by Company
3.1.1 Global Targeted Therapy Drugs for Cancer Annual Sales by Company (2021-2026)
3.1.2 Global Targeted Therapy Drugs for Cancer Sales Market Share by Company (2021-2026)
3.2 Global Targeted Therapy Drugs for Cancer Annual Revenue by Company (2021-2026)
3.2.1 Global Targeted Therapy Drugs for Cancer Revenue by Company (2021-2026)
3.2.2 Global Targeted Therapy Drugs for Cancer Revenue Market Share by Company (2021-2026)
3.3 Global Targeted Therapy Drugs for Cancer Sale Price by Company
3.4 Key Manufacturers Targeted Therapy Drugs for Cancer Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Targeted Therapy Drugs for Cancer Product Location Distribution
3.4.2 Players Targeted Therapy Drugs for Cancer Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TARGETED THERAPY DRUGS FOR CANCER BY GEOGRAPHIC REGION
4.1 World Historic Targeted Therapy Drugs for Cancer Market Size by Geographic Region (2021-2026)
4.1.1 Global Targeted Therapy Drugs for Cancer Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Targeted Therapy Drugs for Cancer Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Targeted Therapy Drugs for Cancer Market Size by Country/Region (2021-2026)
4.2.1 Global Targeted Therapy Drugs for Cancer Annual Sales by Country/Region (2021-2026)
4.2.2 Global Targeted Therapy Drugs for Cancer Annual Revenue by Country/Region (2021-2026)
4.3 Americas Targeted Therapy Drugs for Cancer Sales Growth
4.4 APAC Targeted Therapy Drugs for Cancer Sales Growth
4.5 Europe Targeted Therapy Drugs for Cancer Sales Growth
4.6 Middle East & Africa Targeted Therapy Drugs for Cancer Sales Growth
5 AMERICAS
5.1 Americas Targeted Therapy Drugs for Cancer Sales by Country
5.1.1 Americas Targeted Therapy Drugs for Cancer Sales by Country (2021-2026)
5.1.2 Americas Targeted Therapy Drugs for Cancer Revenue by Country (2021-2026)
5.2 Americas Targeted Therapy Drugs for Cancer Sales by Type (2021-2026)
5.3 Americas Targeted Therapy Drugs for Cancer Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Therapy Drugs for Cancer Sales by Region
6.1.1 APAC Targeted Therapy Drugs for Cancer Sales by Region (2021-2026)
6.1.2 APAC Targeted Therapy Drugs for Cancer Revenue by Region (2021-2026)
6.2 APAC Targeted Therapy Drugs for Cancer Sales by Type (2021-2026)
6.3 APAC Targeted Therapy Drugs for Cancer Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Targeted Therapy Drugs for Cancer by Country
7.1.1 Europe Targeted Therapy Drugs for Cancer Sales by Country (2021-2026)
7.1.2 Europe Targeted Therapy Drugs for Cancer Revenue by Country (2021-2026)
7.2 Europe Targeted Therapy Drugs for Cancer Sales by Type (2021-2026)
7.3 Europe Targeted Therapy Drugs for Cancer Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Therapy Drugs for Cancer by Country
8.1.1 Middle East & Africa Targeted Therapy Drugs for Cancer Sales by Country (2021-2026)
8.1.2 Middle East & Africa Targeted Therapy Drugs for Cancer Revenue by Country (2021-2026)
8.2 Middle East & Africa Targeted Therapy Drugs for Cancer Sales by Type (2021-2026)
8.3 Middle East & Africa Targeted Therapy Drugs for Cancer Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Targeted Therapy Drugs for Cancer
10.3 Manufacturing Process Analysis of Targeted Therapy Drugs for Cancer
10.4 Industry Chain Structure of Targeted Therapy Drugs for Cancer
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Targeted Therapy Drugs for Cancer Distributors
11.3 Targeted Therapy Drugs for Cancer Customer
12 WORLD FORECAST REVIEW FOR TARGETED THERAPY DRUGS FOR CANCER BY GEOGRAPHIC REGION
12.1 Global Targeted Therapy Drugs for Cancer Market Size Forecast by Region
12.1.1 Global Targeted Therapy Drugs for Cancer Forecast by Region (2027-2032)
12.1.2 Global Targeted Therapy Drugs for Cancer Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Targeted Therapy Drugs for Cancer Forecast by Type (2027-2032)
12.7 Global Targeted Therapy Drugs for Cancer Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.1.3 Roche Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.2.3 Novartis Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.3.3 Merck Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.4.3 Pfizer Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.5.3 AstraZeneca Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.6.3 Johnson & Johnson Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 Bristol Myers Squibb
13.7.1 Bristol Myers Squibb Company Information
13.7.2 Bristol Myers Squibb Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.7.3 Bristol Myers Squibb Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Bristol Myers Squibb Main Business Overview
13.7.5 Bristol Myers Squibb Latest Developments
13.8 Bayer
13.8.1 Bayer Company Information
13.8.2 Bayer Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.8.3 Bayer Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bayer Main Business Overview
13.8.5 Bayer Latest Developments
13.9 GSK
13.9.1 GSK Company Information
13.9.2 GSK Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.9.3 GSK Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 GSK Main Business Overview
13.9.5 GSK Latest Developments
13.10 Daiichi Sankyo
13.10.1 Daiichi Sankyo Company Information
13.10.2 Daiichi Sankyo Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.10.3 Daiichi Sankyo Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Daiichi Sankyo Main Business Overview
13.10.5 Daiichi Sankyo Latest Developments
13.11 Amgen
13.11.1 Amgen Company Information
13.11.2 Amgen Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.11.3 Amgen Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Amgen Main Business Overview
13.11.5 Amgen Latest Developments
13.12 Eli Lilly and Company
13.12.1 Eli Lilly and Company Company Information
13.12.2 Eli Lilly and Company Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.12.3 Eli Lilly and Company Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Eli Lilly and Company Main Business Overview
13.12.5 Eli Lilly and Company Latest Developments
13.13 AbbVie
13.13.1 AbbVie Company Information
13.13.2 AbbVie Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.13.3 AbbVie Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 AbbVie Main Business Overview
13.13.5 AbbVie Latest Developments
13.14 Sanofi
13.14.1 Sanofi Company Information
13.14.2 Sanofi Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.14.3 Sanofi Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Sanofi Main Business Overview
13.14.5 Sanofi Latest Developments
13.15 Takeda
13.15.1 Takeda Company Information
13.15.2 Takeda Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.15.3 Takeda Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Takeda Main Business Overview
13.15.5 Takeda Latest Developments
13.16 Boehringer Ingelheim
13.16.1 Boehringer Ingelheim Company Information
13.16.2 Boehringer Ingelheim Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.16.3 Boehringer Ingelheim Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Boehringer Ingelheim Main Business Overview
13.16.5 Boehringer Ingelheim Latest Developments
13.17 Beigene, Ltd.
13.17.1 Beigene, Ltd. Company Information
13.17.2 Beigene, Ltd. Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.17.3 Beigene, Ltd. Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Beigene, Ltd. Main Business Overview
13.17.5 Beigene, Ltd. Latest Developments
13.18 Jiangsu Hengrui Medicine
13.18.1 Jiangsu Hengrui Medicine Company Information
13.18.2 Jiangsu Hengrui Medicine Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.18.3 Jiangsu Hengrui Medicine Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Jiangsu Hengrui Medicine Main Business Overview
13.18.5 Jiangsu Hengrui Medicine Latest Developments
13.19 INNOVENT BIOLOGICS(SUZHOU)
13.19.1 INNOVENT BIOLOGICS(SUZHOU) Company Information
13.19.2 INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.19.3 INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 INNOVENT BIOLOGICS(SUZHOU) Main Business Overview
13.19.5 INNOVENT BIOLOGICS(SUZHOU) Latest Developments
13.20 Betta Pharmaceuticals
13.20.1 Betta Pharmaceuticals Company Information
13.20.2 Betta Pharmaceuticals Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.20.3 Betta Pharmaceuticals Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Betta Pharmaceuticals Main Business Overview
13.20.5 Betta Pharmaceuticals Latest Developments
13.21 Remegen Co.,Ltd.
13.21.1 Remegen Co.,Ltd. Company Information
13.21.2 Remegen Co.,Ltd. Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.21.3 Remegen Co.,Ltd. Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Remegen Co.,Ltd. Main Business Overview
13.21.5 Remegen Co.,Ltd. Latest Developments
13.22 Shanghai Allist Pharmaceuticals
13.22.1 Shanghai Allist Pharmaceuticals Company Information
13.22.2 Shanghai Allist Pharmaceuticals Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.22.3 Shanghai Allist Pharmaceuticals Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Shanghai Allist Pharmaceuticals Main Business Overview
13.22.5 Shanghai Allist Pharmaceuticals Latest Developments
13.23 Innocare
13.23.1 Innocare Company Information
13.23.2 Innocare Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.23.3 Innocare Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Innocare Main Business Overview
13.23.5 Innocare Latest Developments
13.24 Huiyu Pharmaceuticals
13.24.1 Huiyu Pharmaceuticals Company Information
13.24.2 Huiyu Pharmaceuticals Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
13.24.3 Huiyu Pharmaceuticals Targeted Therapy Drugs for Cancer Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Huiyu Pharmaceuticals Main Business Overview
13.24.5 Huiyu Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Targeted Therapy Drugs for Cancer Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Targeted Therapy Drugs for Cancer Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Kinase Inhibitors
Table 4. Major Players of ADCs
Table 5. Major Players of Others
Table 6. Global Targeted Therapy Drugs for Cancer Sales by Type (2021-2026) & (M Units)
Table 7. Global Targeted Therapy Drugs for Cancer Sales Market Share by Type (2021-2026)
Table 8. Global Targeted Therapy Drugs for Cancer Revenue by Type (2021-2026) & ($ million)
Table 9. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Type (2021-2026)
Table 10. Global Targeted Therapy Drugs for Cancer Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Oral Drugs
Table 12. Major Players of Injectable Drugs
Table 13. Major Players of Others
Table 14. Global Targeted Therapy Drugs for Cancer Sales by Administration Route (2021-2026) & (M Units)
Table 15. Global Targeted Therapy Drugs for Cancer Sales Market Share by Administration Route (2021-2026)
Table 16. Global Targeted Therapy Drugs for Cancer Revenue by Administration Route (2021-2026) & ($ million)
Table 17. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Administration Route (2021-2026)
Table 18. Global Targeted Therapy Drugs for Cancer Sale Price by Administration Route (2021-2026) & (US$/Unit)
Table 19. Major Players of Small Molecule Drugs
Table 20. Major Players of Antibody Drugs
Table 21. Major Players of Others
Table 22. Global Targeted Therapy Drugs for Cancer Sales by Molecular Properties (2021-2026) & (M Units)
Table 23. Global Targeted Therapy Drugs for Cancer Sales Market Share by Molecular Properties (2021-2026)
Table 24. Global Targeted Therapy Drugs for Cancer Revenue by Molecular Properties (2021-2026) & ($ million)
Table 25. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Molecular Properties (2021-2026)
Table 26. Global Targeted Therapy Drugs for Cancer Sale Price by Molecular Properties (2021-2026) & (US$/Unit)
Table 27. Global Targeted Therapy Drugs for Cancer Sale by Application (2021-2026) & (M Units)
Table 28. Global Targeted Therapy Drugs for Cancer Sale Market Share by Application (2021-2026)
Table 29. Global Targeted Therapy Drugs for Cancer Revenue by Application (2021-2026) & ($ million)
Table 30. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Application (2021-2026)
Table 31. Global Targeted Therapy Drugs for Cancer Sale Price by Application (2021-2026) & (US$/Unit)
Table 32. Global Targeted Therapy Drugs for Cancer Sales by Company (2021-2026) & (M Units)
Table 33. Global Targeted Therapy Drugs for Cancer Sales Market Share by Company (2021-2026)
Table 34. Global Targeted Therapy Drugs for Cancer Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Company (2021-2026)
Table 36. Global Targeted Therapy Drugs for Cancer Sale Price by Company (2021-2026) & (US$/Unit)
Table 37. Key Manufacturers Targeted Therapy Drugs for Cancer Producing Area Distribution and Sales Area
Table 38. Players Targeted Therapy Drugs for Cancer Products Offered
Table 39. Targeted Therapy Drugs for Cancer Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Targeted Therapy Drugs for Cancer Sales by Geographic Region (2021-2026) & (M Units)
Table 43. Global Targeted Therapy Drugs for Cancer Sales Market Share Geographic Region (2021-2026)
Table 44. Global Targeted Therapy Drugs for Cancer Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Targeted Therapy Drugs for Cancer Sales by Country/Region (2021-2026) & (M Units)
Table 47. Global Targeted Therapy Drugs for Cancer Sales Market Share by Country/Region (2021-2026)
Table 48. Global Targeted Therapy Drugs for Cancer Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Targeted Therapy Drugs for Cancer Sales by Country (2021-2026) & (M Units)
Table 51. Americas Targeted Therapy Drugs for Cancer Sales Market Share by Country (2021-2026)
Table 52. Americas Targeted Therapy Drugs for Cancer Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Targeted Therapy Drugs for Cancer Sales by Type (2021-2026) & (M Units)
Table 54. Americas Targeted Therapy Drugs for Cancer Sales by Application (2021-2026) & (M Units)
Table 55. APAC Targeted Therapy Drugs for Cancer Sales by Region (2021-2026) & (M Units)
Table 56. APAC Targeted Therapy Drugs for Cancer Sales Market Share by Region (2021-2026)
Table 57. APAC Targeted Therapy Drugs for Cancer Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Targeted Therapy Drugs for Cancer Sales by Type (2021-2026) & (M Units)
Table 59. APAC Targeted Therapy Drugs for Cancer Sales by Application (2021-2026) & (M Units)
Table 60. Europe Targeted Therapy Drugs for Cancer Sales by Country (2021-2026) & (M Units)
Table 61. Europe Targeted Therapy Drugs for Cancer Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Targeted Therapy Drugs for Cancer Sales by Type (2021-2026) & (M Units)
Table 63. Europe Targeted Therapy Drugs for Cancer Sales by Application (2021-2026) & (M Units)
Table 64. Middle East & Africa Targeted Therapy Drugs for Cancer Sales by Country (2021-2026) & (M Units)
Table 65. Middle East & Africa Targeted Therapy Drugs for Cancer Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Targeted Therapy Drugs for Cancer Sales by Type (2021-2026) & (M Units)
Table 67. Middle East & Africa Targeted Therapy Drugs for Cancer Sales by Application (2021-2026) & (M Units)
Table 68. Key Market Drivers & Growth Opportunities of Targeted Therapy Drugs for Cancer
Table 69. Key Market Challenges & Risks of Targeted Therapy Drugs for Cancer
Table 70. Key Industry Trends of Targeted Therapy Drugs for Cancer
Table 71. Targeted Therapy Drugs for Cancer Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Targeted Therapy Drugs for Cancer Distributors List
Table 74. Targeted Therapy Drugs for Cancer Customer List
Table 75. Global Targeted Therapy Drugs for Cancer Sales Forecast by Region (2027-2032) & (M Units)
Table 76. Global Targeted Therapy Drugs for Cancer Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Targeted Therapy Drugs for Cancer Sales Forecast by Country (2027-2032) & (M Units)
Table 78. Americas Targeted Therapy Drugs for Cancer Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Targeted Therapy Drugs for Cancer Sales Forecast by Region (2027-2032) & (M Units)
Table 80. APAC Targeted Therapy Drugs for Cancer Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Targeted Therapy Drugs for Cancer Sales Forecast by Country (2027-2032) & (M Units)
Table 82. Europe Targeted Therapy Drugs for Cancer Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Forecast by Country (2027-2032) & (M Units)
Table 84. Middle East & Africa Targeted Therapy Drugs for Cancer Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Targeted Therapy Drugs for Cancer Sales Forecast by Type (2027-2032) & (M Units)
Table 86. Global Targeted Therapy Drugs for Cancer Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Targeted Therapy Drugs for Cancer Sales Forecast by Application (2027-2032) & (M Units)
Table 88. Global Targeted Therapy Drugs for Cancer Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Roche Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 90. Roche Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 91. Roche Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Roche Main Business
Table 93. Roche Latest Developments
Table 94. Novartis Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 95. Novartis Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 96. Novartis Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Novartis Main Business
Table 98. Novartis Latest Developments
Table 99. Merck Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 100. Merck Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 101. Merck Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Merck Main Business
Table 103. Merck Latest Developments
Table 104. Pfizer Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 105. Pfizer Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 106. Pfizer Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Pfizer Main Business
Table 108. Pfizer Latest Developments
Table 109. AstraZeneca Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 110. AstraZeneca Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 111. AstraZeneca Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. AstraZeneca Main Business
Table 113. AstraZeneca Latest Developments
Table 114. Johnson & Johnson Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 115. Johnson & Johnson Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 116. Johnson & Johnson Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Johnson & Johnson Main Business
Table 118. Johnson & Johnson Latest Developments
Table 119. Bristol Myers Squibb Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 120. Bristol Myers Squibb Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 121. Bristol Myers Squibb Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Bristol Myers Squibb Main Business
Table 123. Bristol Myers Squibb Latest Developments
Table 124. Bayer Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 125. Bayer Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 126. Bayer Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Bayer Main Business
Table 128. Bayer Latest Developments
Table 129. GSK Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 130. GSK Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 131. GSK Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. GSK Main Business
Table 133. GSK Latest Developments
Table 134. Daiichi Sankyo Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 135. Daiichi Sankyo Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 136. Daiichi Sankyo Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Daiichi Sankyo Main Business
Table 138. Daiichi Sankyo Latest Developments
Table 139. Amgen Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 140. Amgen Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 141. Amgen Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Amgen Main Business
Table 143. Amgen Latest Developments
Table 144. Eli Lilly and Company Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 145. Eli Lilly and Company Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 146. Eli Lilly and Company Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Eli Lilly and Company Main Business
Table 148. Eli Lilly and Company Latest Developments
Table 149. AbbVie Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 150. AbbVie Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 151. AbbVie Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. AbbVie Main Business
Table 153. AbbVie Latest Developments
Table 154. Sanofi Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 155. Sanofi Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 156. Sanofi Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Sanofi Main Business
Table 158. Sanofi Latest Developments
Table 159. Takeda Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 160. Takeda Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 161. Takeda Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Takeda Main Business
Table 163. Takeda Latest Developments
Table 164. Boehringer Ingelheim Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 165. Boehringer Ingelheim Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 166. Boehringer Ingelheim Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Boehringer Ingelheim Main Business
Table 168. Boehringer Ingelheim Latest Developments
Table 169. Beigene, Ltd. Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 170. Beigene, Ltd. Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 171. Beigene, Ltd. Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. Beigene, Ltd. Main Business
Table 173. Beigene, Ltd. Latest Developments
Table 174. Jiangsu Hengrui Medicine Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 175. Jiangsu Hengrui Medicine Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 176. Jiangsu Hengrui Medicine Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 177. Jiangsu Hengrui Medicine Main Business
Table 178. Jiangsu Hengrui Medicine Latest Developments
Table 179. INNOVENT BIOLOGICS(SUZHOU) Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 180. INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 181. INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 182. INNOVENT BIOLOGICS(SUZHOU) Main Business
Table 183. INNOVENT BIOLOGICS(SUZHOU) Latest Developments
Table 184. Betta Pharmaceuticals Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 185. Betta Pharmaceuticals Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 186. Betta Pharmaceuticals Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 187. Betta Pharmaceuticals Main Business
Table 188. Betta Pharmaceuticals Latest Developments
Table 189. Remegen Co.,Ltd. Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 190. Remegen Co.,Ltd. Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 191. Remegen Co.,Ltd. Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 192. Remegen Co.,Ltd. Main Business
Table 193. Remegen Co.,Ltd. Latest Developments
Table 194. Shanghai Allist Pharmaceuticals Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 195. Shanghai Allist Pharmaceuticals Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 196. Shanghai Allist Pharmaceuticals Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 197. Shanghai Allist Pharmaceuticals Main Business
Table 198. Shanghai Allist Pharmaceuticals Latest Developments
Table 199. Innocare Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 200. Innocare Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 201. Innocare Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 202. Innocare Main Business
Table 203. Innocare Latest Developments
Table 204. Huiyu Pharmaceuticals Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 205. Huiyu Pharmaceuticals Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 206. Huiyu Pharmaceuticals Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 207. Huiyu Pharmaceuticals Main Business
Table 208. Huiyu Pharmaceuticals Latest Developments
Table 1. Targeted Therapy Drugs for Cancer Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Targeted Therapy Drugs for Cancer Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Kinase Inhibitors
Table 4. Major Players of ADCs
Table 5. Major Players of Others
Table 6. Global Targeted Therapy Drugs for Cancer Sales by Type (2021-2026) & (M Units)
Table 7. Global Targeted Therapy Drugs for Cancer Sales Market Share by Type (2021-2026)
Table 8. Global Targeted Therapy Drugs for Cancer Revenue by Type (2021-2026) & ($ million)
Table 9. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Type (2021-2026)
Table 10. Global Targeted Therapy Drugs for Cancer Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of Oral Drugs
Table 12. Major Players of Injectable Drugs
Table 13. Major Players of Others
Table 14. Global Targeted Therapy Drugs for Cancer Sales by Administration Route (2021-2026) & (M Units)
Table 15. Global Targeted Therapy Drugs for Cancer Sales Market Share by Administration Route (2021-2026)
Table 16. Global Targeted Therapy Drugs for Cancer Revenue by Administration Route (2021-2026) & ($ million)
Table 17. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Administration Route (2021-2026)
Table 18. Global Targeted Therapy Drugs for Cancer Sale Price by Administration Route (2021-2026) & (US$/Unit)
Table 19. Major Players of Small Molecule Drugs
Table 20. Major Players of Antibody Drugs
Table 21. Major Players of Others
Table 22. Global Targeted Therapy Drugs for Cancer Sales by Molecular Properties (2021-2026) & (M Units)
Table 23. Global Targeted Therapy Drugs for Cancer Sales Market Share by Molecular Properties (2021-2026)
Table 24. Global Targeted Therapy Drugs for Cancer Revenue by Molecular Properties (2021-2026) & ($ million)
Table 25. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Molecular Properties (2021-2026)
Table 26. Global Targeted Therapy Drugs for Cancer Sale Price by Molecular Properties (2021-2026) & (US$/Unit)
Table 27. Global Targeted Therapy Drugs for Cancer Sale by Application (2021-2026) & (M Units)
Table 28. Global Targeted Therapy Drugs for Cancer Sale Market Share by Application (2021-2026)
Table 29. Global Targeted Therapy Drugs for Cancer Revenue by Application (2021-2026) & ($ million)
Table 30. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Application (2021-2026)
Table 31. Global Targeted Therapy Drugs for Cancer Sale Price by Application (2021-2026) & (US$/Unit)
Table 32. Global Targeted Therapy Drugs for Cancer Sales by Company (2021-2026) & (M Units)
Table 33. Global Targeted Therapy Drugs for Cancer Sales Market Share by Company (2021-2026)
Table 34. Global Targeted Therapy Drugs for Cancer Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Company (2021-2026)
Table 36. Global Targeted Therapy Drugs for Cancer Sale Price by Company (2021-2026) & (US$/Unit)
Table 37. Key Manufacturers Targeted Therapy Drugs for Cancer Producing Area Distribution and Sales Area
Table 38. Players Targeted Therapy Drugs for Cancer Products Offered
Table 39. Targeted Therapy Drugs for Cancer Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Targeted Therapy Drugs for Cancer Sales by Geographic Region (2021-2026) & (M Units)
Table 43. Global Targeted Therapy Drugs for Cancer Sales Market Share Geographic Region (2021-2026)
Table 44. Global Targeted Therapy Drugs for Cancer Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Targeted Therapy Drugs for Cancer Sales by Country/Region (2021-2026) & (M Units)
Table 47. Global Targeted Therapy Drugs for Cancer Sales Market Share by Country/Region (2021-2026)
Table 48. Global Targeted Therapy Drugs for Cancer Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Targeted Therapy Drugs for Cancer Sales by Country (2021-2026) & (M Units)
Table 51. Americas Targeted Therapy Drugs for Cancer Sales Market Share by Country (2021-2026)
Table 52. Americas Targeted Therapy Drugs for Cancer Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Targeted Therapy Drugs for Cancer Sales by Type (2021-2026) & (M Units)
Table 54. Americas Targeted Therapy Drugs for Cancer Sales by Application (2021-2026) & (M Units)
Table 55. APAC Targeted Therapy Drugs for Cancer Sales by Region (2021-2026) & (M Units)
Table 56. APAC Targeted Therapy Drugs for Cancer Sales Market Share by Region (2021-2026)
Table 57. APAC Targeted Therapy Drugs for Cancer Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Targeted Therapy Drugs for Cancer Sales by Type (2021-2026) & (M Units)
Table 59. APAC Targeted Therapy Drugs for Cancer Sales by Application (2021-2026) & (M Units)
Table 60. Europe Targeted Therapy Drugs for Cancer Sales by Country (2021-2026) & (M Units)
Table 61. Europe Targeted Therapy Drugs for Cancer Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Targeted Therapy Drugs for Cancer Sales by Type (2021-2026) & (M Units)
Table 63. Europe Targeted Therapy Drugs for Cancer Sales by Application (2021-2026) & (M Units)
Table 64. Middle East & Africa Targeted Therapy Drugs for Cancer Sales by Country (2021-2026) & (M Units)
Table 65. Middle East & Africa Targeted Therapy Drugs for Cancer Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Targeted Therapy Drugs for Cancer Sales by Type (2021-2026) & (M Units)
Table 67. Middle East & Africa Targeted Therapy Drugs for Cancer Sales by Application (2021-2026) & (M Units)
Table 68. Key Market Drivers & Growth Opportunities of Targeted Therapy Drugs for Cancer
Table 69. Key Market Challenges & Risks of Targeted Therapy Drugs for Cancer
Table 70. Key Industry Trends of Targeted Therapy Drugs for Cancer
Table 71. Targeted Therapy Drugs for Cancer Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Targeted Therapy Drugs for Cancer Distributors List
Table 74. Targeted Therapy Drugs for Cancer Customer List
Table 75. Global Targeted Therapy Drugs for Cancer Sales Forecast by Region (2027-2032) & (M Units)
Table 76. Global Targeted Therapy Drugs for Cancer Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Targeted Therapy Drugs for Cancer Sales Forecast by Country (2027-2032) & (M Units)
Table 78. Americas Targeted Therapy Drugs for Cancer Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Targeted Therapy Drugs for Cancer Sales Forecast by Region (2027-2032) & (M Units)
Table 80. APAC Targeted Therapy Drugs for Cancer Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Targeted Therapy Drugs for Cancer Sales Forecast by Country (2027-2032) & (M Units)
Table 82. Europe Targeted Therapy Drugs for Cancer Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Forecast by Country (2027-2032) & (M Units)
Table 84. Middle East & Africa Targeted Therapy Drugs for Cancer Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Targeted Therapy Drugs for Cancer Sales Forecast by Type (2027-2032) & (M Units)
Table 86. Global Targeted Therapy Drugs for Cancer Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Targeted Therapy Drugs for Cancer Sales Forecast by Application (2027-2032) & (M Units)
Table 88. Global Targeted Therapy Drugs for Cancer Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Roche Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 90. Roche Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 91. Roche Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Roche Main Business
Table 93. Roche Latest Developments
Table 94. Novartis Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 95. Novartis Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 96. Novartis Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Novartis Main Business
Table 98. Novartis Latest Developments
Table 99. Merck Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 100. Merck Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 101. Merck Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Merck Main Business
Table 103. Merck Latest Developments
Table 104. Pfizer Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 105. Pfizer Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 106. Pfizer Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Pfizer Main Business
Table 108. Pfizer Latest Developments
Table 109. AstraZeneca Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 110. AstraZeneca Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 111. AstraZeneca Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. AstraZeneca Main Business
Table 113. AstraZeneca Latest Developments
Table 114. Johnson & Johnson Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 115. Johnson & Johnson Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 116. Johnson & Johnson Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Johnson & Johnson Main Business
Table 118. Johnson & Johnson Latest Developments
Table 119. Bristol Myers Squibb Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 120. Bristol Myers Squibb Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 121. Bristol Myers Squibb Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Bristol Myers Squibb Main Business
Table 123. Bristol Myers Squibb Latest Developments
Table 124. Bayer Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 125. Bayer Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 126. Bayer Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Bayer Main Business
Table 128. Bayer Latest Developments
Table 129. GSK Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 130. GSK Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 131. GSK Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. GSK Main Business
Table 133. GSK Latest Developments
Table 134. Daiichi Sankyo Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 135. Daiichi Sankyo Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 136. Daiichi Sankyo Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Daiichi Sankyo Main Business
Table 138. Daiichi Sankyo Latest Developments
Table 139. Amgen Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 140. Amgen Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 141. Amgen Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Amgen Main Business
Table 143. Amgen Latest Developments
Table 144. Eli Lilly and Company Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 145. Eli Lilly and Company Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 146. Eli Lilly and Company Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Eli Lilly and Company Main Business
Table 148. Eli Lilly and Company Latest Developments
Table 149. AbbVie Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 150. AbbVie Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 151. AbbVie Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. AbbVie Main Business
Table 153. AbbVie Latest Developments
Table 154. Sanofi Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 155. Sanofi Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 156. Sanofi Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Sanofi Main Business
Table 158. Sanofi Latest Developments
Table 159. Takeda Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 160. Takeda Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 161. Takeda Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Takeda Main Business
Table 163. Takeda Latest Developments
Table 164. Boehringer Ingelheim Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 165. Boehringer Ingelheim Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 166. Boehringer Ingelheim Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Boehringer Ingelheim Main Business
Table 168. Boehringer Ingelheim Latest Developments
Table 169. Beigene, Ltd. Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 170. Beigene, Ltd. Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 171. Beigene, Ltd. Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. Beigene, Ltd. Main Business
Table 173. Beigene, Ltd. Latest Developments
Table 174. Jiangsu Hengrui Medicine Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 175. Jiangsu Hengrui Medicine Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 176. Jiangsu Hengrui Medicine Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 177. Jiangsu Hengrui Medicine Main Business
Table 178. Jiangsu Hengrui Medicine Latest Developments
Table 179. INNOVENT BIOLOGICS(SUZHOU) Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 180. INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 181. INNOVENT BIOLOGICS(SUZHOU) Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 182. INNOVENT BIOLOGICS(SUZHOU) Main Business
Table 183. INNOVENT BIOLOGICS(SUZHOU) Latest Developments
Table 184. Betta Pharmaceuticals Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 185. Betta Pharmaceuticals Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 186. Betta Pharmaceuticals Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 187. Betta Pharmaceuticals Main Business
Table 188. Betta Pharmaceuticals Latest Developments
Table 189. Remegen Co.,Ltd. Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 190. Remegen Co.,Ltd. Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 191. Remegen Co.,Ltd. Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 192. Remegen Co.,Ltd. Main Business
Table 193. Remegen Co.,Ltd. Latest Developments
Table 194. Shanghai Allist Pharmaceuticals Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 195. Shanghai Allist Pharmaceuticals Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 196. Shanghai Allist Pharmaceuticals Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 197. Shanghai Allist Pharmaceuticals Main Business
Table 198. Shanghai Allist Pharmaceuticals Latest Developments
Table 199. Innocare Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 200. Innocare Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 201. Innocare Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 202. Innocare Main Business
Table 203. Innocare Latest Developments
Table 204. Huiyu Pharmaceuticals Basic Information, Targeted Therapy Drugs for Cancer Manufacturing Base, Sales Area and Its Competitors
Table 205. Huiyu Pharmaceuticals Targeted Therapy Drugs for Cancer Product Portfolios and Specifications
Table 206. Huiyu Pharmaceuticals Targeted Therapy Drugs for Cancer Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 207. Huiyu Pharmaceuticals Main Business
Table 208. Huiyu Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Targeted Therapy Drugs for Cancer
Figure 2. Targeted Therapy Drugs for Cancer Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Targeted Therapy Drugs for Cancer Sales Growth Rate 2021-2032 (M Units)
Figure 7. Global Targeted Therapy Drugs for Cancer Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Targeted Therapy Drugs for Cancer Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Targeted Therapy Drugs for Cancer Sales Market Share by Country/Region (2025)
Figure 10. Targeted Therapy Drugs for Cancer Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Kinase Inhibitors
Figure 12. Product Picture of ADCs
Figure 13. Product Picture of Others
Figure 14. Global Targeted Therapy Drugs for Cancer Sales Market Share by Type in 2026
Figure 15. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Oral Drugs
Figure 17. Product Picture of Injectable Drugs
Figure 18. Product Picture of Others
Figure 19. Global Targeted Therapy Drugs for Cancer Sales Market Share by Administration Route in 2026
Figure 20. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Administration Route (2021-2026)
Figure 21. Product Picture of Small Molecule Drugs
Figure 22. Product Picture of Antibody Drugs
Figure 23. Product Picture of Others
Figure 24. Global Targeted Therapy Drugs for Cancer Sales Market Share by Molecular Properties in 2026
Figure 25. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Molecular Properties (2021-2026)
Figure 26. Targeted Therapy Drugs for Cancer Consumed in Lung Cancer
Figure 27. Global Targeted Therapy Drugs for Cancer Market: Lung Cancer (2021-2026) & (M Units)
Figure 28. Targeted Therapy Drugs for Cancer Consumed in Breast Cancer
Figure 29. Global Targeted Therapy Drugs for Cancer Market: Breast Cancer (2021-2026) & (M Units)
Figure 30. Targeted Therapy Drugs for Cancer Consumed in Colorectal Cancer
Figure 31. Global Targeted Therapy Drugs for Cancer Market: Colorectal Cancer (2021-2026) & (M Units)
Figure 32. Targeted Therapy Drugs for Cancer Consumed in Stomach Cancer
Figure 33. Global Targeted Therapy Drugs for Cancer Market: Stomach Cancer (2021-2026) & (M Units)
Figure 34. Targeted Therapy Drugs for Cancer Consumed in Liver Cancer
Figure 35. Global Targeted Therapy Drugs for Cancer Market: Liver Cancer (2021-2026) & (M Units)
Figure 36. Targeted Therapy Drugs for Cancer Consumed in Others
Figure 37. Global Targeted Therapy Drugs for Cancer Market: Others (2021-2026) & (M Units)
Figure 38. Global Targeted Therapy Drugs for Cancer Sale Market Share by Application (2025)
Figure 39. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Application in 2026
Figure 40. Targeted Therapy Drugs for Cancer Sales by Company in 2026 (M Units)
Figure 41. Global Targeted Therapy Drugs for Cancer Sales Market Share by Company in 2026
Figure 42. Targeted Therapy Drugs for Cancer Revenue by Company in 2026 ($ millions)
Figure 43. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Company in 2026
Figure 44. Global Targeted Therapy Drugs for Cancer Sales Market Share by Geographic Region (2021-2026)
Figure 45. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Geographic Region in 2026
Figure 46. Americas Targeted Therapy Drugs for Cancer Sales 2021-2026 (M Units)
Figure 47. Americas Targeted Therapy Drugs for Cancer Revenue 2021-2026 ($ millions)
Figure 48. APAC Targeted Therapy Drugs for Cancer Sales 2021-2026 (M Units)
Figure 49. APAC Targeted Therapy Drugs for Cancer Revenue 2021-2026 ($ millions)
Figure 50. Europe Targeted Therapy Drugs for Cancer Sales 2021-2026 (M Units)
Figure 51. Europe Targeted Therapy Drugs for Cancer Revenue 2021-2026 ($ millions)
Figure 52. Middle East & Africa Targeted Therapy Drugs for Cancer Sales 2021-2026 (M Units)
Figure 53. Middle East & Africa Targeted Therapy Drugs for Cancer Revenue 2021-2026 ($ millions)
Figure 54. Americas Targeted Therapy Drugs for Cancer Sales Market Share by Country in 2026
Figure 55. Americas Targeted Therapy Drugs for Cancer Revenue Market Share by Country (2021-2026)
Figure 56. Americas Targeted Therapy Drugs for Cancer Sales Market Share by Type (2021-2026)
Figure 57. Americas Targeted Therapy Drugs for Cancer Sales Market Share by Application (2021-2026)
Figure 58. United States Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 59. Canada Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 60. Mexico Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 61. Brazil Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 62. APAC Targeted Therapy Drugs for Cancer Sales Market Share by Region in 2026
Figure 63. APAC Targeted Therapy Drugs for Cancer Revenue Market Share by Region (2021-2026)
Figure 64. APAC Targeted Therapy Drugs for Cancer Sales Market Share by Type (2021-2026)
Figure 65. APAC Targeted Therapy Drugs for Cancer Sales Market Share by Application (2021-2026)
Figure 66. China Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 67. Japan Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 68. South Korea Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 69. Southeast Asia Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 70. India Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 71. Australia Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 72. China Taiwan Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 73. Europe Targeted Therapy Drugs for Cancer Sales Market Share by Country in 2026
Figure 74. Europe Targeted Therapy Drugs for Cancer Revenue Market Share by Country (2021-2026)
Figure 75. Europe Targeted Therapy Drugs for Cancer Sales Market Share by Type (2021-2026)
Figure 76. Europe Targeted Therapy Drugs for Cancer Sales Market Share by Application (2021-2026)
Figure 77. Germany Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 78. France Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 79. UK Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 80. Italy Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 81. Russia Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 82. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Market Share by Country (2021-2026)
Figure 83. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Market Share by Type (2021-2026)
Figure 84. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Market Share by Application (2021-2026)
Figure 85. Egypt Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 86. South Africa Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 87. Israel Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 88. Turkey Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 89. GCC Countries Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 90. Manufacturing Cost Structure Analysis of Targeted Therapy Drugs for Cancer in 2026
Figure 91. Manufacturing Process Analysis of Targeted Therapy Drugs for Cancer
Figure 92. Industry Chain Structure of Targeted Therapy Drugs for Cancer
Figure 93. Channels of Distribution
Figure 94. Global Targeted Therapy Drugs for Cancer Sales Market Forecast by Region (2027-2032)
Figure 95. Global Targeted Therapy Drugs for Cancer Revenue Market Share Forecast by Region (2027-2032)
Figure 96. Global Targeted Therapy Drugs for Cancer Sales Market Share Forecast by Type (2027-2032)
Figure 97. Global Targeted Therapy Drugs for Cancer Revenue Market Share Forecast by Type (2027-2032)
Figure 98. Global Targeted Therapy Drugs for Cancer Sales Market Share Forecast by Application (2027-2032)
Figure 99. Global Targeted Therapy Drugs for Cancer Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Targeted Therapy Drugs for Cancer
Figure 2. Targeted Therapy Drugs for Cancer Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Targeted Therapy Drugs for Cancer Sales Growth Rate 2021-2032 (M Units)
Figure 7. Global Targeted Therapy Drugs for Cancer Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Targeted Therapy Drugs for Cancer Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Targeted Therapy Drugs for Cancer Sales Market Share by Country/Region (2025)
Figure 10. Targeted Therapy Drugs for Cancer Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Kinase Inhibitors
Figure 12. Product Picture of ADCs
Figure 13. Product Picture of Others
Figure 14. Global Targeted Therapy Drugs for Cancer Sales Market Share by Type in 2026
Figure 15. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Oral Drugs
Figure 17. Product Picture of Injectable Drugs
Figure 18. Product Picture of Others
Figure 19. Global Targeted Therapy Drugs for Cancer Sales Market Share by Administration Route in 2026
Figure 20. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Administration Route (2021-2026)
Figure 21. Product Picture of Small Molecule Drugs
Figure 22. Product Picture of Antibody Drugs
Figure 23. Product Picture of Others
Figure 24. Global Targeted Therapy Drugs for Cancer Sales Market Share by Molecular Properties in 2026
Figure 25. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Molecular Properties (2021-2026)
Figure 26. Targeted Therapy Drugs for Cancer Consumed in Lung Cancer
Figure 27. Global Targeted Therapy Drugs for Cancer Market: Lung Cancer (2021-2026) & (M Units)
Figure 28. Targeted Therapy Drugs for Cancer Consumed in Breast Cancer
Figure 29. Global Targeted Therapy Drugs for Cancer Market: Breast Cancer (2021-2026) & (M Units)
Figure 30. Targeted Therapy Drugs for Cancer Consumed in Colorectal Cancer
Figure 31. Global Targeted Therapy Drugs for Cancer Market: Colorectal Cancer (2021-2026) & (M Units)
Figure 32. Targeted Therapy Drugs for Cancer Consumed in Stomach Cancer
Figure 33. Global Targeted Therapy Drugs for Cancer Market: Stomach Cancer (2021-2026) & (M Units)
Figure 34. Targeted Therapy Drugs for Cancer Consumed in Liver Cancer
Figure 35. Global Targeted Therapy Drugs for Cancer Market: Liver Cancer (2021-2026) & (M Units)
Figure 36. Targeted Therapy Drugs for Cancer Consumed in Others
Figure 37. Global Targeted Therapy Drugs for Cancer Market: Others (2021-2026) & (M Units)
Figure 38. Global Targeted Therapy Drugs for Cancer Sale Market Share by Application (2025)
Figure 39. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Application in 2026
Figure 40. Targeted Therapy Drugs for Cancer Sales by Company in 2026 (M Units)
Figure 41. Global Targeted Therapy Drugs for Cancer Sales Market Share by Company in 2026
Figure 42. Targeted Therapy Drugs for Cancer Revenue by Company in 2026 ($ millions)
Figure 43. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Company in 2026
Figure 44. Global Targeted Therapy Drugs for Cancer Sales Market Share by Geographic Region (2021-2026)
Figure 45. Global Targeted Therapy Drugs for Cancer Revenue Market Share by Geographic Region in 2026
Figure 46. Americas Targeted Therapy Drugs for Cancer Sales 2021-2026 (M Units)
Figure 47. Americas Targeted Therapy Drugs for Cancer Revenue 2021-2026 ($ millions)
Figure 48. APAC Targeted Therapy Drugs for Cancer Sales 2021-2026 (M Units)
Figure 49. APAC Targeted Therapy Drugs for Cancer Revenue 2021-2026 ($ millions)
Figure 50. Europe Targeted Therapy Drugs for Cancer Sales 2021-2026 (M Units)
Figure 51. Europe Targeted Therapy Drugs for Cancer Revenue 2021-2026 ($ millions)
Figure 52. Middle East & Africa Targeted Therapy Drugs for Cancer Sales 2021-2026 (M Units)
Figure 53. Middle East & Africa Targeted Therapy Drugs for Cancer Revenue 2021-2026 ($ millions)
Figure 54. Americas Targeted Therapy Drugs for Cancer Sales Market Share by Country in 2026
Figure 55. Americas Targeted Therapy Drugs for Cancer Revenue Market Share by Country (2021-2026)
Figure 56. Americas Targeted Therapy Drugs for Cancer Sales Market Share by Type (2021-2026)
Figure 57. Americas Targeted Therapy Drugs for Cancer Sales Market Share by Application (2021-2026)
Figure 58. United States Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 59. Canada Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 60. Mexico Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 61. Brazil Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 62. APAC Targeted Therapy Drugs for Cancer Sales Market Share by Region in 2026
Figure 63. APAC Targeted Therapy Drugs for Cancer Revenue Market Share by Region (2021-2026)
Figure 64. APAC Targeted Therapy Drugs for Cancer Sales Market Share by Type (2021-2026)
Figure 65. APAC Targeted Therapy Drugs for Cancer Sales Market Share by Application (2021-2026)
Figure 66. China Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 67. Japan Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 68. South Korea Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 69. Southeast Asia Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 70. India Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 71. Australia Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 72. China Taiwan Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 73. Europe Targeted Therapy Drugs for Cancer Sales Market Share by Country in 2026
Figure 74. Europe Targeted Therapy Drugs for Cancer Revenue Market Share by Country (2021-2026)
Figure 75. Europe Targeted Therapy Drugs for Cancer Sales Market Share by Type (2021-2026)
Figure 76. Europe Targeted Therapy Drugs for Cancer Sales Market Share by Application (2021-2026)
Figure 77. Germany Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 78. France Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 79. UK Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 80. Italy Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 81. Russia Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 82. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Market Share by Country (2021-2026)
Figure 83. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Market Share by Type (2021-2026)
Figure 84. Middle East & Africa Targeted Therapy Drugs for Cancer Sales Market Share by Application (2021-2026)
Figure 85. Egypt Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 86. South Africa Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 87. Israel Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 88. Turkey Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 89. GCC Countries Targeted Therapy Drugs for Cancer Revenue Growth 2021-2026 ($ millions)
Figure 90. Manufacturing Cost Structure Analysis of Targeted Therapy Drugs for Cancer in 2026
Figure 91. Manufacturing Process Analysis of Targeted Therapy Drugs for Cancer
Figure 92. Industry Chain Structure of Targeted Therapy Drugs for Cancer
Figure 93. Channels of Distribution
Figure 94. Global Targeted Therapy Drugs for Cancer Sales Market Forecast by Region (2027-2032)
Figure 95. Global Targeted Therapy Drugs for Cancer Revenue Market Share Forecast by Region (2027-2032)
Figure 96. Global Targeted Therapy Drugs for Cancer Sales Market Share Forecast by Type (2027-2032)
Figure 97. Global Targeted Therapy Drugs for Cancer Revenue Market Share Forecast by Type (2027-2032)
Figure 98. Global Targeted Therapy Drugs for Cancer Sales Market Share Forecast by Application (2027-2032)
Figure 99. Global Targeted Therapy Drugs for Cancer Revenue Market Share Forecast by Application (2027-2032)
